Aardvark Therapeutics, Inc. Common Stock (AARD)
NASDAQ·Healthcare·Biotechnology
$1.16
+4.05%
Mkt Cap $26.26M
Analyst Ratings
Buy
2
Hold
4
Sell
1
Price Target (10 analysts)
$2.88
Range $2.00 – $4.00
Implied Upside
+149.4%
Consensus $2.88 vs current $1.16